Action LA JOLLA PHARM
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues LA JOLLA PHARM Other OTC

Actions

Cours en clôture Other OTC
Autres places de cotation
- USD - Graphique intraday de LA JOLLA PHARM
2022 La Jolla Pharmaceutical annonce des changements de direction CI
2022 Innoviva, Inc. (NasdaqGS:INVA) a finalisé l'acquisition de La Jolla Pharmaceutical Company (NasdaqCM:LJPC). CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
La Jolla Pharmaceutical Announces Management Changes
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index
Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.
La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
Equity Alert - The M&A Class Action Firm Announces the Investigation of La Jolla Pharmaceutical Co. - LJPC
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership (Form 4)
SHAREHOLDER ALERT: Weiss Law Investigates La Jolla Pharmaceutical Company
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action LJPC
  4. Action
  5. Actualités LA JOLLA PHARM
  6. Autres langues